GSK_ Annual_Report_2021-22

117 ( ` in lakhs) Year ended March 31, 2022 Year ended March 31, 2021 Loan given to related parties (204,60.00) - Net proceeds from sale of brands and other identified assets (net of tax) (Discontinued Operations) 1265,60.61 - Indirect taxes payables on sale of brands and other identified assets (Discontinued Operations) 295,77.67 - Interest received 44,40.65 54,55.98 Cash (outflow) / inflow from investing activities before exceptional items (444,77.18) 226,14.85 Exceptional items: Proceeds from sale of property 32,34.24 1,84.09 Advance received towards disposal of Vemgal assets - 180,00.00 Income taxes on Exceptional items (7,23.06) (42.12) Net cash (outflow) / inflow from investing activities B (419,66.00) 407,56.82 C. CASH FLOWS FROM FINANCING ACTIVITIES Repayments of borrowings (2.40) (15.30) Interest paid, other than on lease liabilities (25.28) (34.99) Interest paid on lease liabilities (1,73.70) (3,18.15) Principal payment of lease liabilities (15,59.35) (14,83.08) Dividend paid to company’s shareholders (506,63.50) (677,04.43) Net cash outflow from financing activities C (524,24.23) (695,55.95) Net (decrease)/ increase in cash and cash equivalents (A + B + C) (124,11.08) 306,87.41 Cash and cash equivalents at the beginning of the year 404,90.20 98,02.79 Cash and cash equivalents at the end of the year 280,79.12 404,90.20 Net (decrease)/ increase in cash and cash equivalents (124,11.08) 306,87.41 NOTES: Cash and cash equivalents include: Balances with banks Current accounts 50,73.12 205,83.20 Term deposits with original maturity period of less than three months 230,06.00 199,07.00 Total 280,79.12 404,90.20 The above Standalone Cash Flow Statement has been prepared under the “Indirect Method” as set out in Ind AS - 7 ‘Statement of Cash Flows’ The accompanying notes 1 to 63 are an integral part of the Standalone Financial Statements In terms of our report attached For Deloitte Haskins & Sells LLP For and on behalf of the Board of Directors Chartered Accountants R. S. Karnad Chairperson DIN: 00008064 Firm‘s Registration No. 117366W/W-100018 S. Venkatesh Managing Director DIN: 07263117 J. Chandy CFO & Whole-time Director DIN: 09530618 Rupen K. Bhatt D. Sundaram Audit Committee Chairman DIN: 00016304 Partner A. Nadkarni Company Secretary FCS 10460 Membership No. 046930 Mumbai, May 16, 2022 Mumbai, May 16, 2022